微芯生物：2025年半年度归属于上市公司股东的净利润为29592228.83元

Core Viewpoint - Microchip Biotech announced a significant increase in revenue and net profit for the first half of 2025, indicating strong financial performance and growth potential in the biotech sector [2] Financial Performance - The company achieved a revenue of 406,598,517.70 yuan for the first half of 2025, representing a year-on-year growth of 34.56% [2] - The net profit attributable to shareholders of the listed company was reported at 29,592,228.83 yuan [2]